Outcomes of Arterial Embolization vs Covered Stents for Delayed Massive Hemorrhage After Pancreatic or Biliary

Yukihiro Watanabe1, Ken Nakazawa2, Kenichiro Takase3

  • 1Department of Gastroenterological Surgery, Saitama Medical University International Medical Center, Hidaka, Saitama, 1397-1 Yamane350-1298, Japan. watanb@saitama-med.ac.jp.

Insights

Covered stent placement (CSP) is a superior endovascular treatment for delayed massive hemorrhage (DMH) after pancreatic or biliary surgery. CSP significantly reduces major hepatic complications and mortality compared to arterial embolization (AE).

Area of Science:

  • Interventional Radiology
  • Vascular Surgery
  • Hepatobiliary Surgery

Background:

  • Delayed massive hemorrhage (DMH) is a serious complication following pancreatic or biliary surgery.
  • Covered stent placement (CSP) is increasingly used for DMH management, but its benefits require further evaluation.
  • Conflicting results exist regarding the efficacy of CSP versus traditional methods.

Purpose of the Study:

  • To compare the short- and medium-term outcomes of arterial embolization (AE) and CSP for managing DMH.
  • To assess the effectiveness of endovascular treatments for hepatic artery hemorrhage post-pancreaticobiliary surgery.

Main Methods:

  • Retrospective analysis of patients treated with AE (n=50) or CSP (n=20) for DMH from January 2009 to December 2019.
  • Evaluation of major hepatic complications, in-hospital mortality, and 1-year mortality.
  • Analysis of factors including age, sex, reintervention, arterial variants, and portal vein stenosis.

Main Results:

  • CSP demonstrated no in-hospital mortality versus 32% for AE (p=0.003).
  • CSP showed significantly lower rates of major hepatic complications (10% vs. 44%, p=0.011) and 1-year mortality (25% vs. 54%, p=0.035) compared to AE.
  • Technical success and reintervention rates were similar between CSP and AE.

Conclusions:

  • Covered stent placement is superior to arterial embolization for managing delayed massive hemorrhage from hepatic arteries.
  • CSP significantly reduces major hepatic complications and mortality in this patient population.
  • CSP offers improved outcomes for patients experiencing DMH after pancreatic or biliary surgery.
Abstract

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
63
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
42
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
168